This analysis showed that bladder (24, 25), breast (26–28), colorectal (29, 30), esophageal (31, 32), gastric (33), head and neck (34, 35), kidney (36–39), leukemia (40), lung (41–46), lymphoma (47), ovarian (48) and pancreatic cancer (49–52) have higher expression of GLUT1 compared with normal tissues. The gene discussed is SLC2A1; the disease is leukemia.